| Metric | შპს ჯორჯიან ფარმაცევტიკალსი | შპს Europharma Georgia ევროფარმა ჯორჯია | შპს საფ ფარმა |
|---|---|---|---|
| Growth | |||
| Revenue | ₾7.9m₾6.6m | ₾6.4m₾5.4m | ₾6.4m₾6.5m |
| Revenue growth | 18.9% | 19.8% | -1.3% |
| Profitability | |||
| EBITDA | ₾2.8m₾1.9m | ₾651k₾577k | ₾1.4m₾1.2m |
| EBITDA margin | 35.4%29.4% | 10.2%10.8% | 22.5%18.4% |
| Net profit | ₾2.6m₾1.4m | ₾643k₾577k | |
| ₾1.5m₾1.1m |
| Net margin | 33.6%20.8% | 10.0%10.8% | 23.0%17.7% |
| Balance sheet | |||
| Total assets | ₾7.9m₾5.6m | ₾5.1m₾4.9m | ₾5.3m₾5.4m |
| Total equity | ₾7.9m₾5.1m | ₾3.1m₾2.2m | ₾2.7m₾1.2m |
| ROE | 33.5%27.0% | 20.6%26.4% | 54.6%93.9% |